2017
HDR Monotherapy in Prostate Cancer: Radiobiological Considerations When Determining Biologically Effective Dose in Clinical Trials
Tien C, Carlson D, Nath R, Chen Z. HDR Monotherapy in Prostate Cancer: Radiobiological Considerations When Determining Biologically Effective Dose in Clinical Trials. Brachytherapy 2017, 16: s31. DOI: 10.1016/j.brachy.2017.04.038.Peer-Reviewed Original Research
2012
On the Use of Biologically Effective Dose (BED) and Iso-Effective Dose (IED) in Radiobiological Evaluations of Permanent Brachytherapy With Proliferating Tumors
Chen Z, Nath R. On the Use of Biologically Effective Dose (BED) and Iso-Effective Dose (IED) in Radiobiological Evaluations of Permanent Brachytherapy With Proliferating Tumors. International Journal Of Radiation Oncology • Biology • Physics 2012, 84: s755. DOI: 10.1016/j.ijrobp.2012.07.2020.Peer-Reviewed Original ResearchBiologically Effective DoseIso-effective doseProliferating tumorsPermanent brachytherapyRadiobiological evaluationEffective doseDose